Evangelos Cholongitas | Hepatology | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Evangelos Cholongitas, Laiko General Hospital of Athens, Greece

Evangelos Cholongitas
Affiliation Laiko General Hospital of Athens
Country Greece
Scopus ID 55399959500
Documents 323
Citations 12,006
h-index 57
Subject Area Hepatology
Event Global Diseases Research Awards
ORCID 0000-0002-3645-582X
Google Scholar View Profile

The Best Researcher Award recognizes the scholarly achievements and scientific contributions of Evangelos Cholongitas, a clinician and academic researcher affiliated with the Laiko General Hospital of Athens in Greece. His work in hepatology has contributed to the advancement of liver disease management, transplantation medicine, portal hypertension research, and evidence-based clinical hepatology.[1] Through a substantial body of peer-reviewed publications, citation impact, and international collaboration, Cholongitas has established a recognized academic profile within gastroenterology and liver research communities.[2]

Abstract

Evangelos Cholongitas is recognized for sustained contributions to hepatology and liver transplantation research. His scientific work has addressed major clinical challenges related to chronic liver disease, portal hypertension, transplantation outcomes, renal impairment in liver disorders, and evidence-based therapeutic approaches. The Best Researcher Award acknowledges his academic productivity, citation influence, and continuing role in advancing translational and clinical hepatology research within international scientific communities.[1]

Keywords

Hepatology, Liver Transplantation, Gastroenterology, Chronic Liver Disease, Clinical Research, Portal Hypertension, Hepatic Disorders, Evidence-Based Medicine, Liver Failure, Academic Research Excellence

Introduction

Hepatology remains an important medical discipline focused on the diagnosis, management, and prevention of liver-related diseases. Research in this area contributes significantly to improving patient outcomes in cirrhosis, viral hepatitis, liver transplantation, metabolic liver disease, and hepatocellular carcinoma.[4] Evangelos Cholongitas has contributed extensively to these areas through clinical studies, systematic reviews, and collaborative investigations that support evidence-based hepatology practice.[2]

The Best Researcher Award presented within the framework of the Global Diseases Research Awards recognizes researchers whose work demonstrates measurable scholarly influence and international academic engagement. Cholongitas’ publication record, citation performance, and ongoing scientific contributions support his recognition within this category.

Research Profile

Evangelos Cholongitas has developed a comprehensive academic profile in hepatology with research interests spanning liver transplantation, chronic liver disease, portal hypertension, and transplantation-associated complications. His publication portfolio includes peer-reviewed journal articles, collaborative studies, and evidence synthesis reports indexed in international academic databases.[1]

  • Extensive publication record in clinical hepatology and transplantation medicine
  • High citation impact demonstrating international scholarly visibility
  • Research involvement in evidence-based therapeutic approaches for liver diseases
  • Contributions to collaborative clinical investigations and systematic reviews
  • Academic participation in international hepatology and gastroenterology research communities

Research Contributions

The research contributions of Evangelos Cholongitas are associated with clinically relevant investigations into liver disease progression, transplantation outcomes, and complications associated with hepatic dysfunction. His studies frequently evaluate diagnostic indicators, patient survival factors, renal impairment in liver disease, and post-transplant clinical management.

Several of his publications have addressed the relationship between liver transplantation and renal function, particularly in patients with advanced cirrhosis and portal hypertension. These studies contribute to improving patient assessment strategies and long-term clinical management in transplantation medicine.

  • Clinical studies on liver transplantation outcomes
  • Research on renal impairment associated with chronic liver disease
  • Evidence-based analyses in hepatology practice
  • Systematic reviews and meta-analyses in gastroenterology
  • Collaborative translational research in hepatic disorders

Publications

Evangelos Cholongitas has contributed to numerous publications in hepatology and transplantation medicine. Representative publication themes include chronic liver disease management, transplantation outcomes, renal dysfunction in cirrhosis, and portal hypertension research.[4]

  1. Studies addressing risk factors for kidney impairment following liver transplantation
  2. Research evaluating predictors of survival in chronic liver disease
  3. Evidence synthesis studies in transplantation hepatology
  4. Clinical analyses involving portal hypertension and cirrhosis management
  5. Collaborative investigations published in peer-reviewed gastroenterology journals

Selected scholarly works have been indexed through major international databases and include DOI-linked academic publications supporting accessibility and citation tracking.

Research Impact

The scholarly impact of Evangelos Cholongitas is reflected in his extensive citation metrics, publication output, and h-index performance within hepatology-related scientific literature. Citation indicators demonstrate sustained engagement with his research findings across international academic and clinical communities.[1]

His work has contributed to discussions regarding liver transplantation assessment, chronic liver disease management, and clinical decision-making in hepatology. The integration of clinical evidence into practice-oriented research supports the translational significance of his academic contributions.

Award Suitability

The Best Researcher Award recognizes measurable academic influence, scholarly productivity, and sustained scientific engagement. Evangelos Cholongitas demonstrates these criteria through a combination of publication activity, international citation impact, and contributions to clinically relevant hepatology research.

  • Established publication record in peer-reviewed medical journals
  • Substantial international citation performance
  • Contributions to liver transplantation and hepatology research
  • Demonstrated evidence-based clinical research engagement
  • Active academic presence within global hepatology research networks

Conclusion

Evangelos Cholongitas has contributed substantially to hepatology and transplantation medicine through sustained clinical research, publication activity, and evidence-based scientific investigations. His scholarly work addresses important aspects of chronic liver disease management and transplantation outcomes, supporting advancements in patient care and academic hepatology.[2] Recognition through the Best Researcher Award reflects his continuing role in international liver disease research and academic medicine.

References

1. Elsevier. (n.d.). Scopus author details: Evangelos Cholongitas (Author ID: 55399959500). Scopus. https://www.scopus.com/authid/detail.uri?authorId=55399959500

2. Google Scholar. (n.d.). Evangelos Cholongitas citation profile.
https://scholar.google.com/citations?user=Mur4BnEAAAAJ&hl=en

3. Marelli, L., Stigliano, R., Triantos, C., Senzolo, M., Cholongitas, E., Davies, N., Tibballs, J., Meyer, T., Patch, D. W., & Burroughs, A. K. (2007). Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. CardioVascular and Interventional Radiology, 30(1), 6–25. https://doi.org/10.1007/s00270-006-0062-3

4. Tsochatzis, E. A., Gurusamy, K. S., Ntaoula, S., Cholongitas, E., Davidson, B. R., & Burroughs, A. K. (2011). Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. Journal of Hepatology.
https://doi.org/10.1016/j.jhep.2010.07.033

5. Cholongitas, E., Papatheodoridis, G. V., Vangeli, M., Terreni, N., Patch, D., & Burroughs, A. K. (2006). Systematic review: The model for end-stage liver disease—Should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics, 24(6), 859–870.
https://doi.org/10.1111/j.1365-2036.2005.02691.x

Cleophas Kyama | Human Papilloma Virus | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Cleophas Kyama
Affiliation Jomo Kenyatta University Of Agriculture And Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Human Papilloma Virus
Event Global Diseases Research Awards
ORCID 0000-0001-6459-1514

Cleophas Kyama is affiliated with Jomo Kenyatta University Of Agriculture And Technology in Kenya and is recognized for scholarly contributions in the field of Human Papilloma Virus research. The researcher has established a significant academic profile through publications, interdisciplinary collaboration, and measurable citation impact within biomedical and infectious disease studies.[1] The present article highlights the research profile, scientific contributions, publication influence, and award suitability of the researcher within the framework of the Global Diseases Research Awards initiative.[2]

Abstract

The academic work of Cleophas Kyama reflects a sustained contribution to infectious disease research with a primary focus on Human Papilloma Virus studies and related biomedical investigations. The researcher has demonstrated measurable scholarly impact through peer-reviewed publications, citation performance, and interdisciplinary engagement within the scientific community.[1] The documented research activities support advancements in epidemiological understanding, disease prevention strategies, and translational healthcare applications relevant to global disease management. The researcher’s publication metrics and collaborative scientific output position the profile as a notable candidate for international academic recognition programs.

Keywords

  • Human Papilloma Virus
  • Biomedical Research
  • Global Diseases
  • Scientific Publications
  • Research Excellence
  • Infectious Diseases
  • Scholarly Impact

Introduction

Research related to Human Papilloma Virus has become increasingly important in the context of global public health due to its association with infectious disease transmission, cancer epidemiology, and preventive healthcare strategies. Academic researchers working within this field contribute substantially to evidence-based clinical approaches, vaccination awareness, screening methodologies, and disease surveillance systems. Cleophas Kyama has participated in scholarly efforts that align with these objectives through research dissemination and scientific collaboration.[1]

The growing importance of multidisciplinary biomedical research has further strengthened the role of investigators who integrate epidemiology, molecular science, and healthcare innovation into applied disease research. Within this framework, publication metrics such as citation counts and h-index values provide measurable indicators of scientific influence and research visibility.

Research Profile

Cleophas Kyama is associated with Jomo Kenyatta University Of Agriculture And Technology, an institution recognized for academic and scientific research activities in Kenya. The researcher’s Scopus profile identifies an established publication record consisting of 65 indexed documents and a citation count exceeding 2,600 citations.[1] The h-index value of 29 reflects consistent scholarly engagement and sustained citation performance across multiple publications.

The researcher’s work demonstrates participation in collaborative scientific initiatives involving disease-related investigations, biomedical analysis, and public health-oriented research themes. Such activities support broader international objectives related to healthcare improvement and scientific knowledge dissemination.

Research Contributions

The research contributions associated with Cleophas Kyama include scientific investigations connected to infectious diseases, molecular biology, and Human Papilloma Virus-related healthcare research. The researcher has contributed to studies that enhance understanding of disease progression, diagnostic methodologies, and public health implications associated with viral infections.

Additional contributions include participation in interdisciplinary collaborations that integrate laboratory science, epidemiological analysis, and clinical relevance. Such multidisciplinary approaches are essential for advancing translational research and improving disease prevention frameworks.

  • Contribution to Human Papilloma Virus-related scientific literature.
  • Participation in infectious disease research collaborations.
  • Support for evidence-based biomedical investigations.
  • Scientific dissemination through peer-reviewed publications.

Publications

The publication profile of Cleophas Kyama reflects sustained academic productivity within indexed scientific databases. The researcher’s scholarly output demonstrates engagement with internationally accessible journals and collaborative research publications. Citation metrics indicate that the published work has received scholarly recognition and continued academic referencing.[1]

  1. Research articles related to Human Papilloma Virus and infectious diseases.
  2. Collaborative biomedical and public health investigations.
  3. Metabolomics Profile and Pro-Apoptotic Activity of Solanecio mannii Root Extracts Against Human Cervical Cancer Cell Lines. [4]
  4. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. [5]

Digital Object Identifier (DOI) systems associated with scientific publications facilitate global accessibility, citation tracking, and long-term preservation of scholarly literature.

Research Impact

The citation performance associated with Cleophas Kyama’s scholarly record indicates substantial research visibility and academic engagement. An h-index of 29 suggests that multiple publications have achieved consistent citation activity within the scientific literature.[1] Citation metrics serve as quantitative indicators of the influence and applicability of published research across academic and clinical domains.

Research focused on Human Papilloma Virus contributes to broader public health objectives including disease prevention, screening awareness, and healthcare policy development. The dissemination of scientifically validated findings supports both local and international disease management frameworks.

Award Suitability

The research profile of Cleophas Kyama demonstrates characteristics commonly associated with international academic recognition programs. These include sustained publication output, measurable citation performance, interdisciplinary collaboration, and contributions to infectious disease research.[2]

The Global Diseases Research Awards initiative recognizes researchers whose work contributes to scientific advancement, healthcare innovation, and evidence-based disease understanding. Within this context, the researcher’s documented academic metrics and research specialization support suitability for recognition under the Research Excellence Award category.

Conclusion

Cleophas Kyama has established a scholarly profile characterized by research productivity, citation impact, and scientific engagement within Human Papilloma Virus and infectious disease studies. The combination of indexed publications, measurable academic influence, and interdisciplinary contributions supports recognition within international research award frameworks.[1] Continued participation in biomedical research initiatives is expected to further strengthen the dissemination of scientific knowledge related to disease prevention and public health advancement.

References

      1. Elsevier. (n.d.). Scopus author details: Cleophas Kyama, Author ID 57216717397. Scopus.
        https://www.scopus.com/authid/detail.uri?authorId=57216717397
      2. Global Diseases Research Awards. (n.d.). Research Excellence Award program overview.
        https://globaldiseases.org/
      3. World Health Organization. (n.d.). Global infectious disease research and public health priorities.
        https://www.who.int/
      4. Elbasyouni, A., Kyama, M. C., El-Shemy, H. A., & Mwitari, P. G. (2025). Metabolomics profile and pro-apoptotic activity of Solanecio mannii root extracts against human cervical cancer cell lines. PLOS ONE.
        https://doi.org/10.1371/journal.pone.0323680
      5. Elbasyouni, A., Kyama, M. C., El-Shemy, H. A., & Mwitari, P. G. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE, 20(5), e0323680. https://doi.org/10.1371/journal.pone.0323680

Samir Abbès | Mycotoxicology | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Samir Abbès — Higher Institute of Biotechnology of Monastir

Research Profile
Affiliation Higher Institute of Biotechnology of Monastir
Country Tunisia
Scopus ID 13407983200
Documents 46
Citations 1471
h-index 24
Subject Area Mycotoxicology
Event Global Diseases Research Awards

The Research Excellence Award recognizes scholarly achievements and sustained scientific contributions within the interdisciplinary field of mycotoxicology and disease-related biosciences. Samir Abbès, affiliated with the Higher Institute of Biotechnology of Monastir, Tunisia, has contributed to scientific investigations concerning fungal toxins, food safety, toxicological assessment, and public health implications associated with mycotoxin exposure.[1] His academic profile demonstrates measurable research impact through peer-reviewed publications, citation performance, and collaborative scientific activity within international research networks.[2]

Abstract

This academic recognition profile documents the scholarly activities and scientific contributions of Samir Abbès in the field of mycotoxicology. The profile highlights research productivity, publication metrics, interdisciplinary collaboration, and scientific impact associated with toxicological investigations and food safety sciences. Particular emphasis is placed on the evaluation of fungal toxins, biological risk assessment, and disease-related environmental health research. Citation performance and bibliometric indicators further demonstrate sustained academic engagement and international research visibility.[1

Keywords

  • Mycotoxicology
  • Food Safety
  • Toxicology
  • Disease Research
  • Fungal Contamination
  • Biotechnology
  • Research Excellence Award
  • Global Diseases Research Awards

Introduction

Mycotoxicology represents a critical area of biomedical and environmental research due to the widespread occurrence of fungal toxins in agricultural products and food systems. Research in this discipline contributes to understanding toxin biosynthesis, contamination pathways, toxicological mechanisms, and public health risks. Samir Abbès has participated in scientific studies associated with toxin monitoring, toxicological analysis, and preventive biotechnology approaches related to foodborne diseases and contamination risks.[2]

The recognition of scholarly achievements through international academic awards provides visibility to researchers contributing to scientific advancement and interdisciplinary collaboration. The Research Excellence Award associated with the Global Diseases Research Awards highlights scientific contributions demonstrating measurable impact through publications, citations, and specialized research outcomes.

Research Profile

Samir Abbès is affiliated with the Higher Institute of Biotechnology of Monastir in Tunisia and has developed a scholarly profile focused on toxicological sciences, fungal contamination analysis, and food safety research. Bibliometric records indexed through Scopus identify 46 scholarly documents associated with the author profile and an h-index of 24, indicating sustained citation influence within the scientific community.[1]

Research activities linked to the profile include multidisciplinary collaborations involving toxicology, biotechnology, microbiology, and disease prevention studies. The citation count exceeding 1400 citations reflects broad academic engagement and utilization of the published work by other researchers in related scientific disciplines.[2]

Research Contributions

The research contributions associated with Samir Abbès primarily address toxicological assessments of mycotoxins and their implications for food quality and human health. Scientific investigations in this field commonly involve analytical detection methods, exposure evaluation, toxicological pathways, and mitigation strategies intended to reduce contamination risks.[5]

  • Research on fungal toxin contamination and toxicological assessment methodologies.
  • Scientific studies involving food safety monitoring and environmental exposure analysis.
  • Interdisciplinary collaboration within biotechnology and disease prevention research initiatives.
  • Contribution to peer-reviewed literature addressing public health implications of mycotoxins.

These contributions support ongoing scientific understanding of contamination control strategies and toxicological risk evaluation in agricultural and biomedical systems

Publications

Selected research publications and indexed scholarly outputs demonstrate engagement with toxicological and bioscience research topics. Representative publication themes include fungal toxin characterization, toxic effects analysis, and biotechnology applications in food safety monitoring.[2]

  1. Studies related to mycotoxin contamination and toxicological risk evaluation in food systems.
  2. Determination of 22 mycotoxins in wheat grains cultivated in two Moroccan climatic areas by UHPLC-MS/MS.[3]
  3. Comparative study of phenolic profile and antioxidant activities of different parts of Ziziphus lotus using aqueous, hydroalcoholic and pulsed electric field extractions [4]

Associated publications contribute to the scientific literature utilized by researchers working in food safety, toxicology, and disease prevention disciplines.

Research Impact

Bibliometric indicators demonstrate measurable academic impact associated with the research profile. Citation metrics and h-index performance indicate that published studies have contributed to scientific dialogue and have been referenced within international research literature. Such indicators are commonly used to evaluate research visibility, influence, and scholarly dissemination.[1]

The interdisciplinary relevance of mycotoxicology research extends to food security, disease prevention, agricultural safety, and environmental toxicology. Research outputs associated with Samir Abbès contribute to broader scientific efforts focused on reducing biological contamination risks and improving public health awareness.[5]

Award Suitability

The scholarly profile of Samir Abbès aligns with the objectives of the Global Diseases Research Awards due to demonstrated contributions in toxicology, disease-related bioscience, and environmental health research. Publication productivity, citation performance, interdisciplinary engagement, and sustained scientific activity collectively support consideration for research excellence recognition.

Recognition through academic award programs may further support international visibility, collaborative opportunities, and continued scientific advancement in mycotoxicology and related disease research disciplines.[2]

Conclusion

Samir Abbès has established a research profile characterized by scientific contributions in mycotoxicology, toxicological assessment, and food safety sciences. Bibliometric indicators, publication activity, and interdisciplinary engagement demonstrate sustained participation in internationally relevant scientific research. The Research Excellence Award profile reflects scholarly achievements associated with disease-related bioscience investigations and environmental health studies.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Samir Abbès, Author ID 13407983200. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=13407983200
  2. Global Diseases Research Awards. (n.d.). Research Excellence Award program overview
    .    https://globaldiseases.org/
  3. Zinedine, A., Durand, N., Meile, J.-C., Abbès, S., Ben Salah-Abbès, J., & Brabet, C. (2025). Determination of 22 mycotoxins in wheat grains cultivated in two Moroccan climatic areas by UHPLC-MS/MS. Food Chemistry, 495, 146356.
    https://doi.org/10.1016/j.foodchem.2025.146356
  4. Dhif, H., Ben Salah-Abbès, J., Abbès, S., Calleja-Gómez, M., Pallarés, N., & Berrada, H. (2025). Comparative study of phenolic profile and antioxidant activities of different parts of Ziziphus lotus using aqueous, hydroalcoholic and pulsed electric field extractions. Microchemical Journal, Article 114815.
    https://doi.org/10.1016/j.microc.2025.114815
  5. World Health Organization. (n.d.). Mycotoxins and public health implications
    .    https://www.who.int/news-room/fact-sheets/detail/mycotoxins

Gulnara Yuldasheva | Drug Synergy | Women Researcher Award

Published on by Global Diseases Research

Women Researcher Award

Research Profile
Affiliation Scientific Center for Anti-Infective Drug
Country Kazakhstan
Scopus ID 21735405800
Documents 7
Citations 35
h-index 5
Subject Area Drug synergy
Event Global Diseases Research Awards
ORCID 0000-0003-2881-0307

Gulnara Yuldasheva is associated with the Scientific Center for Anti-Infective Drug in Kazakhstan and has contributed to the advancement of research in drug synergy and anti-infective therapeutic studies. Her scholarly work reflects a focused engagement in antimicrobial research, pharmaceutical sciences, and collaborative approaches to disease-related investigations. The academic profile demonstrates measurable research visibility through indexed publications, citations, and international scholarly recognition.[1]

Abstract

The Women Researcher Award recognizes academic and scientific contributions that demonstrate relevance, scholarly consistency, and engagement with emerging challenges in biomedical and pharmaceutical sciences. Gulnara Yuldasheva has contributed to the field of anti-infective drug research with particular attention to drug synergy, antimicrobial investigations, and interdisciplinary pharmaceutical approaches. Her research activities are represented through indexed scientific publications and citation-based academic visibility, indicating active participation in internationally recognized scientific communication.[1][2]

Keywords

  • Drug synergy
  • Anti-infective research
  • Pharmaceutical sciences
  • Biomedical research
  • Women in science
  • Global Diseases Research Awards

Introduction

Research in anti-infective therapeutics continues to play a significant role in addressing global public health challenges related to infectious diseases and antimicrobial resistance. Scientific investigations involving drug synergy provide insights into the combined effects of therapeutic compounds and contribute to the optimization of treatment strategies. Researchers engaged in this domain support evidence-based approaches that may improve clinical outcomes and pharmaceutical innovation.[2]

Gulnara Yuldasheva’s academic profile reflects participation in research initiatives connected with anti-infective drug development and interdisciplinary pharmaceutical studies. Her scholarly contributions demonstrate engagement with research dissemination through indexed databases and internationally accessible scientific literature. Such contributions align with the broader objectives of scientific collaboration and innovation in health-related research environments.[1]

Research Profile

The research profile of Gulnara Yuldasheva is associated with studies in anti-infective pharmacology and drug synergy analysis. Her work has contributed to the understanding of therapeutic interactions and scientific approaches relevant to infectious disease management. Indexed publications and citation metrics indicate continuing scholarly engagement within biomedical and pharmaceutical research communities.[1]

  • Affiliated with the Scientific Center for Anti-Infective Drug.
  • Research specialization includes drug synergy and anti-infective therapeutics.
  • Indexed scientific publications available through Scopus.
  • Recognized through measurable citation impact and academic visibility.
  • Engaged in interdisciplinary biomedical and pharmaceutical studies.

Research Contributions

Research contributions associated with Gulnara Yuldasheva include scientific investigations into anti-infective compounds, synergistic drug interactions, and pharmaceutical research methodologies. Such studies support broader scientific understanding related to therapeutic combinations and their relevance in infectious disease management.[2]

Drug synergy research is important for evaluating combined therapeutic effectiveness, minimizing resistance development, and identifying optimized treatment approaches. Through scholarly publication activity, Yuldasheva has contributed to ongoing scientific discussions in this specialized area of pharmaceutical sciences and biomedical investigation.[3]

Publications

The publication record associated with Gulnara Yuldasheva reflects contributions to scientific literature indexed within internationally recognized academic databases. Her scholarly output demonstrates participation in peer-reviewed communication relevant to anti-infective pharmacology and biomedical research.[1]

  1. Research studies addressing anti-infective therapeutic strategies and drug interaction analysis.
  2. Molecular Modeling of the Anti-HIV Activity Mechanism of Iodine-Containing Drugs Armenicum and FS-1Article link copied! [3]
  3. Iodine-Based Coordination Compounds: A Strategy Toward Antibiotic Potentiation [4]

Research Impact

Research impact may be evaluated through publication indexing, citation activity, and scholarly engagement across scientific platforms. The citation profile associated with Gulnara Yuldasheva demonstrates recognition within academic literature and indicates that her work has contributed to discussions related to pharmaceutical and anti-infective sciences.[1]

The documented h-index and citation metrics reflect measurable academic visibility within the scientific community. Such indicators support the significance of continued research participation and contribution to interdisciplinary biomedical knowledge dissemination.[1]

Award Suitability

The Women Researcher Award within the Global Diseases Research Awards framework recognizes scientific contributions that support research excellence, innovation, and scholarly engagement in health sciences. Gulnara Yuldasheva’s profile demonstrates alignment with these objectives through her involvement in anti-infective drug research, indexed scientific output, and measurable citation impact.[5]

Her academic activities indicate sustained participation in biomedical and pharmaceutical investigations relevant to global health and therapeutic innovation. The combination of publication visibility, research specialization, and international indexing supports the suitability of recognition within a research-oriented academic award context.[1]

Conclusion

Gulnara Yuldasheva has contributed to scientific research associated with anti-infective therapeutics and drug synergy studies through indexed publications and interdisciplinary academic engagement. Her scholarly profile reflects measurable research visibility and participation in pharmaceutical science communication. The academic contributions and citation-based impact presented within this profile demonstrate relevance to contemporary biomedical research and support recognition within the Women Researcher Award category of the Global Diseases Research Awards.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Gulnara Yuldasheva, Author ID 21735405800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21735405800
  2. World Health Organization. (2023). Antimicrobial resistance and anti-infective therapeutic research.
    https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  3. Yuldasheva, G. A., Argirova, R., & Ilin, A. I. (2023). Molecular modeling of the anti-HIV activity mechanism of iodine-containing drugs Armenicum and FS-1. ACS Omega, 8(9), 8617–8624
    https://doi.org/10.1021/acsomega.2c07720

  4. Shepilov, D., Askarova, D., Seisembekova, A., Turganbay, S., Jumagaziyeva, A., Bukeyeva, T., Yuldasheva, G., Temir, N., Ivanova, L. N., Zubenko, N., & Kenesheva, S. (2026). Iodine-based coordination compounds: A strategy toward antibiotic potentiation. International Journal of Molecular Sciences, 27(10), 4292.
    https://doi.org/10.3390/ijms27104292

  5. Global Diseases Research Awards. (n.d.). Women Researcher Award recognition and event information.
    https://globaldiseases.org/

Njeumi Felix | Epidemiology | Excellence in Research Award

Published on by Global Diseases Research

Excellence in Research Award

Njeumi Felix
Food and Agriculture Organization of the United Nations
Academic Profile
Affiliation Food and Agriculture Organization of the United Nations
Country Italy
Scopus ID 6506444570
Documents 32
Citations 633
h-index 13
Subject Area Epidemiology
Event Global Diseases Research Awards

Njeumi Felix is an epidemiology researcher and international scientific coordinator associated with the Food and Agriculture Organization of the United Nations. His academic and professional activities are primarily connected to infectious disease surveillance, transboundary animal disease control, and global veterinary public health initiatives. His scholarly work reflects contributions to disease eradication programs, epidemiological assessment methodologies, and collaborative international research activities addressing livestock health management and sustainable agricultural development.[1][2]

Abstract

This academic recognition article provides a scholarly overview of Njeumi Felix and his contributions to epidemiology and infectious disease research. His professional activities include research coordination, epidemiological investigations, and participation in global veterinary health initiatives. His scientific work contributes to disease surveillance systems, veterinary public health frameworks, and collaborative international efforts addressing transboundary animal diseases and livestock health management.[1][3]

Keywords

Epidemiology; Veterinary Science; Infectious Diseases; Disease Surveillance; Peste des Petits Ruminants; Global Disease Eradication; Animal Health; Veterinary Public Health; Transboundary Diseases; International Research Collaboration.

Introduction

Epidemiological research plays a significant role in understanding infectious disease transmission and strengthening international disease prevention systems. Veterinary public health initiatives have become increasingly important due to the global impact of transboundary animal diseases on agricultural economies, livestock productivity, and food security. Njeumi Felix has contributed to these scientific and institutional efforts through research coordination, disease surveillance activities, and international collaborative programs.[2]

His academic profile demonstrates involvement in multidisciplinary approaches related to disease eradication frameworks and veterinary epidemiology. These contributions support evidence-based decision-making processes within international animal health management systems.[4]

Research Profile

The research profile of Njeumi Felix reflects scholarly engagement in epidemiology, disease surveillance, and veterinary health management. His Scopus-indexed publication record includes research articles related to infectious disease risk analysis, surveillance strategies, vaccine assessment methodologies, and global disease control initiatives.[1]

His academic activities also indicate substantial international collaboration across scientific institutions and disease control programs. These collaborative efforts contribute to advancing epidemiological understanding and improving veterinary public health infrastructure in multiple geographic regions.[5]

Research Contributions

Njeumi Felix has contributed to research associated with Peste des Petits Ruminants and related transboundary animal diseases. His scientific involvement includes epidemiological modeling, disease risk mapping, surveillance frameworks, and international disease eradication planning activities.[3]

His work additionally supports multidisciplinary veterinary public health approaches integrating scientific research, policy coordination, and institutional collaboration. These contributions strengthen global disease management strategies and support sustainable livestock health systems.[4]

Publications

Selected scientific publications associated with Njeumi Felix include studies addressing epidemiological surveillance, disease risk analysis, vaccine evaluation, and transboundary disease management strategies.[3][4]

  • Risk mapping of Peste des Petits Ruminants virus spread using spatial multicriteria decision analysis methodologies in regions surrounding the Black Sea.[3]
  • Research concerning vaccine thermotolerance criteria for improving disease prevention and veterinary immunization programs.[4]

Research Impact

The scholarly impact of Njeumi Felix is reflected through citation metrics, collaborative publications, and continued participation in global disease research initiatives. His Scopus profile indicates a significant citation record and measurable academic influence within epidemiology and veterinary science research communities.[1]

Beyond academic publication metrics, his work contributes to practical disease management frameworks and international policy-oriented veterinary health programs. These activities support improved livestock health systems and long-term infectious disease mitigation strategies.[2][5]

Award Suitability

Njeumi Felix demonstrates suitability for recognition within the Global Diseases Research Awards due to his sustained contributions to epidemiology, veterinary public health, and infectious disease research. His scholarly activities reflect international collaboration, scientific productivity, and engagement with disease eradication initiatives relevant to global health priorities.[5]

The combination of academic publications, institutional leadership activities, and measurable research impact supports his recognition within international academic and scientific communities focused on disease prevention and epidemiological advancement.[1]

Conclusion

Njeumi Felix has contributed to the advancement of epidemiological research and international veterinary health initiatives through collaborative scientific work and institutional engagement. His academic profile demonstrates ongoing involvement in disease surveillance, infectious disease management, and evidence-based veterinary public health strategies. The impact of his research supports recognition within scholarly platforms dedicated to global disease research and epidemiological studies.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Njeumi Felix, Author ID 6506444570. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506444570
  2. Food and Agriculture Organization of the United Nations. (n.d.). Global animal health and disease control initiatives. FAO.
    https://www.fao.org/
  3. Arede, M., Beltrán-Alcrudo, D., Benfield, C., Casal, J., & Njeumi, F. (2024). Risk mapping of Peste des Petits Ruminants virus spread in nine countries surrounding the Black Sea: a spatial multicriteria decision analysis approach. Frontiers in Veterinary Science.
    https://doi.org/10.3389/fvets.2026.1783624
  4. Bodjo, C. S., et al. (2023). Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses.
    https://doi.org/10.3390/v17091151
  5. Global Diseases Research Awards. (n.d.). International academic recognition and disease research initiatives.
    https://globaldiseases.org/